Non-Surgical Treatment for Prostate Cancer

By utilizing the advanced technology of Intensity-Modulated Radiation Therapy (IMRT), we deliver highly precise radiation treatment. This approach minimizes radiation exposure to surrounding healthy organs while administering a high dose to the prostate, achieving treatment outcomes comparable to, or even surpassing, those of surgery.

Providing Medical Institution

SAITO YUKOUKAI HOSPITAL

〒567-0085
Ibaraki City Saito Asagi 7-2-18

Google Map https://www.saito-yukoukai-hp.jp/

Specialty

This is a comprehensive medical checkup using advanced medical equipment, excluding PET.

Eligibility Criteria/Exclusions for Treatment

- No contraindications to radiation therapy, such as complications from collagen diseases (e.g., scleroderma) or hereditary disorders (e.g., xeroderma pigmentosum). - Must have a trusted urologist in the patient’s home country to ensure follow-up care, including treatment efficacy evaluation and management of side effects after radiation. - Must be able to stay in Japan for approximately 8 weeks, covering both the preparation and radiation periods, and be available for consultations during that time. - Outpatient treatment must be feasible (hospitalization is not permitted). - The patient must personally sign the consent forms for examinations and treatments issued by our clinic, and it is preferable to have an additional family member’s signature. - No prior history of radiation therapy to the prostate or nearby areas. - No pacemakers or internal metal implants, allowing for MRI examinations at our clinic. - Must be able to maintain a supine position without movement for approximately 30 minutes. - Diagnosed with prostate cancer through pathological examination based on more than 10 prostate biopsies, with a confirmed Gleason's score. The diagnostic report must be provided. - Prostate imaging diagnosis performed with an MRI of 1.5 Tesla or higher, confirming localized prostate cancer (T-factor of T1-3 in the TNM classification). The imaging data and diagnostic report must be submitted. - Imaging studies (CT, MRI, bone scintigraphy, FDG-PET/CT) must confirm no lymph node or distant metastasis (N0M0 in the TNM classification). The imaging data and diagnostic report must be submitted. - Baseline PSA (iPSA) must have been measured, and the test report must be provided. - It is preferable if hormone therapy (CAB therapy) has been administered for 6 to 12 months before the start of radiation therapy. - Treatment may be declined if deemed inappropriate for our clinic.

Precautions / Contraindications

Radiation therapy cannot be provided if there is a history of prior radiation treatment to the prostate. Hospitalization for treatment is not permitted. Hormone therapy cannot be continued at our clinic during the radiation therapy period.